Results per Page:
A misbehaving master mitochondrial regulator causes diabetes in mice
From The Hockenbery Lab, Translational Science and Therapeutics Division
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Dr. David Hockenbery receives the 2022 Ali Al-Johani Award
Gastroenterologist honored for his compassion and care of patients
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Can a tumor that acts like a microbe help us develop better cancer therapies?
Understanding the genetics underlying spontaneous regression of an infectious tumor in Tasmanian devils could point us toward new treatment targets
Fnip1 at the interplay for Polycystic kidney diseases
from the Iritani lab, Basic Sciences Division
Getting to the heart of complex cancer mutations
From the Clurman lab, Human Biology Division
Machine learning provides new insights into tumor suppression
Algorithm illuminated surprising metabolic effects of important cancer gene
Drs. Michael Emerman and Nina Salama elected to Fellowship in the American Academy of Microbiology
Celebrating faculty and staff achievements
New use for a cell toxin found to inhibit survival proteins in cancer cells
Findings could lead to new drug to lower resistance to cancer therapies
Gaining gastrointestinal GVHD control
Phase III clinical trial on drug therapy to combat graft-vs.-host disease in stem-cell patients shows significant reduction in deaths